연구성과로 돌아가기
2025 연구자 정보 (251 / 657)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Author Name | 제1저자 여부 | 교신저자 여부 | Address | ResearcherID | ORCID | Paper Title | WoS Edition | 최상위 JCR(%) | WoS Category | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
|
Jang, Eun Jin (Jang, EJ) |
Andong Natl Univ, Dept Data Sci, Andong, South Korea Andong Natl Univ, Dept Informat Stat, Andong, South Korea |
|
|
[JCR상위 12.9] Cancer incidence and the influence of immunosuppressive agents in Korean patients with systemic lupus erythematosus: a retrospective cohort study [JCR상위 18.1] Cardiovascular disease risk in Korean patients with systemic lupus erythematosus compared to diabetes mellitus and the general population [JCR상위 25.0] Mortality patterns of SLE and the associated risk factors in Korean patients: a nationwide cohort study |
SCIE | 12.9 |
RHEUMATOLOGY MULTIDISCIPLINARY SCIENCES |
sungyk@hanyang.ac.kr; skchomd@hanyang.ac.kr; yeahnah@naver.com; julie6002@naver.com; jejstat@gmail.com; jsyoung@cau.ac.kr; sungyk@hanyang.ac.kr; |
||
|
Jeon, Yena (Jeon, Y) |
Kyungpook Natl Univ, Dept Stat, Daegu, South Korea |
|
|
[JCR상위 12.9] Cancer incidence and the influence of immunosuppressive agents in Korean patients with systemic lupus erythematosus: a retrospective cohort study [JCR상위 18.1] Cardiovascular disease risk in Korean patients with systemic lupus erythematosus compared to diabetes mellitus and the general population [JCR상위 25.0] Mortality patterns of SLE and the associated risk factors in Korean patients: a nationwide cohort study |
SCIE | 12.9 |
RHEUMATOLOGY MULTIDISCIPLINARY SCIENCES |
sungyk@hanyang.ac.kr; skchomd@hanyang.ac.kr; yeahnah@naver.com; julie6002@naver.com; jejstat@gmail.com; jsyoung@cau.ac.kr; sungyk@hanyang.ac.kr; |
||
|
Jun, Jae-Bum (Jun, JB) |
제1저자 | Hanyang Univ, Hosp Rheumat Dis, Dept Rheumatol, Seoul, South Korea |
|
|
[JCR상위 12.9] Efficacy and safety of epaminurad, a potent hURAT1 inhibitor, in patients with gout: a randomized, placebo-controlled, dose-finding study | SCIE | 12.9 | RHEUMATOLOGY | drsong@cau.ac.kr; | |
|
Jung, Sun-Young (Jung, SY) |
Chung Ang Univ, Coll Pharm, Seoul, South Korea |
|
|
[JCR상위 12.9] Cancer incidence and the influence of immunosuppressive agents in Korean patients with systemic lupus erythematosus: a retrospective cohort study [JCR상위 18.1] Cardiovascular disease risk in Korean patients with systemic lupus erythematosus compared to diabetes mellitus and the general population [JCR상위 25.0] Mortality patterns of SLE and the associated risk factors in Korean patients: a nationwide cohort study |
SCIE | 12.9 |
RHEUMATOLOGY MULTIDISCIPLINARY SCIENCES |
sungyk@hanyang.ac.kr; skchomd@hanyang.ac.kr; yeahnah@naver.com; julie6002@naver.com; jejstat@gmail.com; jsyoung@cau.ac.kr; sungyk@hanyang.ac.kr; |
||
|
Kim, Hyun Ah (Kim, HA) |
Hallym Univ, Sacred Heart Hosp, Dept Internal Med, Div Rheumatol, Anyang, South Korea Keimyung Univ, Dept Neurol, Sch Med, Daegu, South Korea Keimyung Univ, Brain Res Inst, Sch Med, Daegu, South Korea |
|
|
[JCR상위 12.9] Efficacy and safety of epaminurad, a potent hURAT1 inhibitor, in patients with gout: a randomized, placebo-controlled, dose-finding study [JCR상위 6.7] Clinical features of secondary BPPV: A nation-wide multicenter study |
SCIE | 6.7 |
RHEUMATOLOGY NEUROSCIENCES;OTORHINOLARYNGOLOGY |
drsong@cau.ac.kr; eeksung@schmc.ac.kr; |
||
|
Kim, Sang-Hyon (Kim, SH) |
Keimyung Univ, Coll Med, Dept Internal Med, Div Rheumatol, Daegu, South Korea |
|
|
[JCR상위 12.9] Efficacy and safety of epaminurad, a potent hURAT1 inhibitor, in patients with gout: a randomized, placebo-controlled, dose-finding study | SCIE | 12.9 | RHEUMATOLOGY | drsong@cau.ac.kr; | ||
|
Lee, Hye-Soon (Lee, HS) |
Hanyang Univ, Guri Hosp, Dept Internal Med, Div Rheumatol,Coll Med, Guri, South Korea |
|
|
[JCR상위 12.9] Efficacy and safety of epaminurad, a potent hURAT1 inhibitor, in patients with gout: a randomized, placebo-controlled, dose-finding study | SCIE | 12.9 | RHEUMATOLOGY | drsong@cau.ac.kr; | ||
|
Lee, Seung-Geun (Lee, SG) |
Pusan Natl Univ, Sch Med, Dept Internal Med, Div Rheumatol, Busan, South Korea |
|
|
[JCR상위 12.9] Efficacy and safety of epaminurad, a potent hURAT1 inhibitor, in patients with gout: a randomized, placebo-controlled, dose-finding study | SCIE | 12.9 | RHEUMATOLOGY | drsong@cau.ac.kr; | ||
|
Lee, Shin-Seok (Lee, SS) |
Chonnam Natl Univ Med Sch & Hosp, Dept Internal Med, Div Rheumatol, Gwangju, South Korea |
|
|
[JCR상위 12.9] Efficacy and safety of epaminurad, a potent hURAT1 inhibitor, in patients with gout: a randomized, placebo-controlled, dose-finding study | SCIE | 12.9 | RHEUMATOLOGY | drsong@cau.ac.kr; | ||
|
Lim, Doo-Ho (Lim, DH) |
Univ Ulsan, Coll Med, Ulsan Univ Hosp, Div Rheumatol,Dept Internal Med, Ulsan, South Korea |
|
|
[JCR상위 12.9] Efficacy and safety of epaminurad, a potent hURAT1 inhibitor, in patients with gout: a randomized, placebo-controlled, dose-finding study | SCIE | 12.9 | RHEUMATOLOGY | drsong@cau.ac.kr; | ||
|
Lim, Mie Jin (Lim, MJ) |
Inha Univ, Dept Internal Med, Div Rheumatol, Incheon, South Korea |
|
|
[JCR상위 12.9] Efficacy and safety of epaminurad, a potent hURAT1 inhibitor, in patients with gout: a randomized, placebo-controlled, dose-finding study | SCIE | 12.9 | RHEUMATOLOGY | drsong@cau.ac.kr; | ||
|
Park, Yong-Beom (Park, YB) |
Yonsei Univ, Coll Med, Dept Internal Med, Div Rheumatol, Seoul, South Korea |
IVH-2192-2023 Park, Yong-Beom |
|
[JCR상위 12.9] Efficacy and safety of epaminurad, a potent hURAT1 inhibitor, in patients with gout: a randomized, placebo-controlled, dose-finding study | SCIE | 12.9 | RHEUMATOLOGY | drsong@cau.ac.kr; | ||
|
Song, Jung Soo (Song, JS) |
교신저자 | Chung Ang Univ, Sch Med, Dept Internal Med, Div Rheumatol, 102 Heukseok Ro, Seoul 06973, South Korea |
|
|
[JCR상위 12.9] Efficacy and safety of epaminurad, a potent hURAT1 inhibitor, in patients with gout: a randomized, placebo-controlled, dose-finding study | SCIE | 12.9 | RHEUMATOLOGY | drsong@cau.ac.kr; | |
|
Suh, Chang-Hee (Suh, CH) |
Ajou Univ, Sch Med, Dept Rheumatol, Suwon, South Korea |
|
|
[JCR상위 12.9] Efficacy and safety of epaminurad, a potent hURAT1 inhibitor, in patients with gout: a randomized, placebo-controlled, dose-finding study | SCIE | 12.9 | RHEUMATOLOGY | drsong@cau.ac.kr; | ||
|
Sung, Yoon-Kyoung (Sung, YK) |
교신저자 |
Hanyang Univ, Dept Rheumatol, Hosp Rheumat Dis, Seoul 04763, South Korea Hanyang Univ, Inst Rheumatol Res, Seoul, South Korea Hanyang Univ Hosp Rheumat Dis, Dept Rheumatol, Seoul 04763, South Korea Hanyang Univ, Dept Rheumatol, Hosp Rheumat Dis, Seoul, South Korea |
|
|
[JCR상위 12.9] Cancer incidence and the influence of immunosuppressive agents in Korean patients with systemic lupus erythematosus: a retrospective cohort study [JCR상위 18.1] Cardiovascular disease risk in Korean patients with systemic lupus erythematosus compared to diabetes mellitus and the general population [JCR상위 25.0] Mortality patterns of SLE and the associated risk factors in Korean patients: a nationwide cohort study |
SCIE | 12.9 |
RHEUMATOLOGY MULTIDISCIPLINARY SCIENCES |
sungyk@hanyang.ac.kr; skchomd@hanyang.ac.kr; yeahnah@naver.com; julie6002@naver.com; jejstat@gmail.com; jsyoung@cau.ac.kr; sungyk@hanyang.ac.kr; |
페이지 이동: